Sale Continues String of Successes in Transportation Security and Public Safety Markets
WILMINGTON, MA, Jun 28, 2010 (MARKETWIRE via COMTEX) --
Implant Sciences Corporation (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for the homeland security and defense markets, today announced an order totaling over $850,000 for its Quantum Sniffer(TM) QS-H150 Portable Explosive Trace Detector. The equipment will be deployed for use in transportation security and public safety applications in southeastern China.
"We are very proud of this order," stated Jeff Tehan, Vice President of Sales and Marketing for Implant Sciences. "Our initial successes in this market validated our technical and operational advantages. The continued selection of the Quantum Sniffer by a growing number of Chinese municipalities demonstrates the consistent quality and reliability of our solutions."
Glenn D. Bolduc, Implant Sciences CEO, commented, "We are delighted with the fine performance of our in-country distributor and their continued penetration of the Chinese markets. With this order, Implant Sciences will have shipped over 650 units to China representing revenues of approximately $15 million."
About the Quantum Sniffer QS-H150
The QS-H150 Quantum Sniffer is a hand-held explosive trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Science's QS-H100 and QS-H150 Portable Explosives Detectors have been Designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the U.S. government or by other law enforcement agencies or commercial consumers of security products; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Implant Sciences Corporation
SOURCE: Implant Sciences Corporation